Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Sunday, September 28

2:50 PM - 3:00 PM PT

116 - Two-Year Clinical Outcomes Following Ablative Radiotherapy for Unfavorable Prostate Tumors (ABRUPT)
Speaker: Arcangeli, Stefano, MD - University of Milan Bicocca, Milan, Milan
2:50 PM - 3:00 PM PT

129 - Sequential Chemo-Immunotherapy plus Optimized Thoracic Radiotherapy vs. Standard Thoracic Radiotherapy for Elderly and/ or Frail Stage III Non-Small-Cell Lung Cancer: A Randomized Open-Label Controlled Trial of iLCC-3
Speaker: Qi, Wei-Xiang, MD, RT - Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai
2:50 PM - 3:00 PM PT

136 - E2F1-Fanconi Anemia Complementation Group I (FANCI) Mediates Oncogenic BRAF-Driven Radiation Resistance in Anaplastic Thyroid Cancer
Speaker: Yang, Linlin, MD, PhD - City of Hope Comprehensive Cancer Center, Duarte, CA
2:51 PM - 2:58 PM PT

124 - Tracking Changes in B Cell Antibodies in Cervical Cancer Patients Treated with Chemoradiation and Immunotherapy on GOG 9929
Speaker: Kim, Sangwoo, MD - University of California, San Diego, La Jolla, CA
2:58 PM - 3:05 PM PT

125 - Hypofractionated Radiotherapy as a Potential Alternative to Conventional Treatment for Cervical Cancer in Resource-Limited Setting: A Prospective Comparative Analysis
Speaker: Mallum, Abba, MD, PhD - Department of Radiotherapy and Oncology, Inkosi Albert Luthuli Central Hospital, Durban
3:00 PM - 3:10 PM PT

103 - An Initial Report of Memory Avoidance Whole Brain Radiotherapy to Treat Brain Metastases: A Prospective Phase 2 Trial
Speaker: Palmer, Joshua, MD - The James Cancer Hospital & Solove Research Institute, Columbus, OH
3:00 PM - 3:10 PM PT

110 - IMPARC: A Prospective Trial of Stereotactic Proton Reirradiation for Locoregionally Recurrent Rectal Cancer
Speaker: Dalwadi, Poonam, MD, BS - Washington University/B-JH/SLCH Consortium, St. Louis, MO
3:00 PM - 3:10 PM PT

117 - Outcomes Following Radiation Therapy and Radical Prostatectomy in Patients with High Risk Prostate Cancer in a Similar Access System
Speaker: Kumar, Abhishek, MD, MAS - The Oncology Institute of Hope and Innovation, Cerritos, CA
3:00 PM - 3:10 PM PT

130 - High-Dimensional Immunophenotyping of Patients with Localized Non-Small Cell Lung Cancer (NSCLC) Reveals Distinct Immune Cell Subsets Predictive of Disease-Free Survival (DFS) in AFT-16 and LCMC3 Phase II Immunotherapy Clinical Trials
Speaker: Eustace, Nicholas, MD, PhD - City of Hope National Medical Center, Duarte, CA
3:00 PM - 3:10 PM PT

137 - Exploiting Dependencies Created By KEAP1/NFE2L2 Mutations in NSCLC to Overcome Radiation Resistance
Speaker: Mai, Wilson, MD, PhD - Stanford University Cancer Center, Stanford, CA
3:05 PM - 3:12 PM PT

126 - A Real-World Comparison of Moderated Hypofractionated Radiotherapy and Conventional Fractionated Radiotherapy in Cervical Cancer
Speaker: Zeng, Zheng, MD - Peking Union Medical College Hospital, Beijing, Beijing
3:10 PM - 3:20 PM PT

104 - Deep Learning-Based Personalized Blood Dosimetry (OncoBlood) for Circulating Blood Cell Exposure Predicts Radiation-Induced Severe Lymphopenia and Survival Outcomes in Craniospinal Irradiation
Speaker: Seo, Sang Hoon, MD, PhD Candidate - Oncosoft, Seoul, SEO